Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 145,439 | 164,886 | 110,825 | 184,218 | 994,242 |
| Receivables | 973,888 | 906,455 | 936,259 | 929,372 | 940,358 |
| Inventories | 88,262 | 89,132 | 84,954 | 87,967 | 71,741 |
| Income taxes - deferred | 171,815 | 153,328 | 166,907 | 166,739 | 182,255 |
| TOTAL | $1,518,604 | $1,401,260 | $1,396,277 | $1,477,955 | $2,299,985 |
| Non-Current Assets | |||||
| PPE Net | 781,427 | 799,771 | 806,043 | 820,593 | 821,526 |
| Intangibles | 6,876,588 | 6,831,377 | 6,850,799 | 6,899,140 | 5,914,286 |
| Other Non-Current Assets | 274,825 | 280,971 | 273,352 | 233,503 | 188,932 |
| TOTAL | $7,932,840 | $7,912,119 | $7,930,194 | $7,953,236 | $6,924,744 |
| Total Assets | $9,451,444 | $9,313,379 | $9,326,471 | $9,431,191 | $9,224,729 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 554,356 | 654,395 | 835,910 | 994,675 | 629,238 |
| Accounts payable and accrued liabilities | 971,092 | 906,764 | 928,162 | 998,682 | 1,137,326 |
| TOTAL | $1,525,448 | $1,561,159 | $1,764,072 | $1,993,357 | $1,766,564 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,365,257 | 3,370,522 | 3,367,847 | 3,332,931 | 3,594,643 |
| aiOther Non-Current Liabilities | 655,285 | 657,327 | 639,543 | 645,923 | 618,319 |
| TOTAL | $4,029,939 | $4,037,221 | $4,017,435 | $3,987,238 | $4,220,161 |
| Total Liabilities | $5,555,387 | $5,598,380 | $5,781,507 | $5,980,595 | $5,986,725 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 158,650 | 158,337 | 157,759 | 158,286 | 157,349 |
| Common Shares | 2,151 | 2,146 | 2,146 | 2,146 | 2,146 |
| Retained earnings | 4,395,647 | 4,263,599 | 4,101,066 | 3,945,037 | 3,797,796 |
| Other shareholders' equity | 37,107 | 13,736 | 17,588 | 55,339 | 55,235 |
| TOTAL | $3,896,057 | $3,714,999 | $3,544,964 | $3,450,596 | $3,238,004 |
| Total Liabilities And Equity | $9,451,444 | $9,313,379 | $9,326,471 | $9,431,191 | $9,224,729 |